Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinsons disease

1 Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease Therapeutics and Clinical Risk Management, May 10, 2013    Evidence Based Medicine

2 Multicentre analysis of 178,992 type 2 diabetes patients revealed better metabolic control despite higher rates of hypertension, stroke, dementia and repeated inpatient care in patients with comorbid Parkinsons disease Parkinsonism & Related Disorders, May 8, 2013

3 Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome Journal of Neural Transmission, April 30, 2013    Review Article

4 Pharmacologic Treatment of Anxiety Disorders in Parkinson Disease The American Journal of Geriatric Psychiatry, May 16, 2013

5 Nicotine from edible Solanaceae and risk of Parkinson disease Annals of Neurology , May 15, 2013    Review Article

6 Cost-effectiveness of deep brain stimulation in patients with Parkinsons disease Movement Disorders, April 29, 2013

7 A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia BMC Psychiatry, May 23, 2013

8 Degradation of Stored Movement Representations in the Parkinsonian Brain and the Impact of Levodopa Neuropsychologia, May 2, 2013

9 Pharmacokinetic Considerations for the Use of Levodopa in the Treatment of Parkinson Disease: Focus on Levodopa/Carbidopa/Entacapone for Treatment of Levodopa-Associated Motor Complications Clinical Neuropharmacology, May 16, 2013

10 Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinsons disease International Journal of Urology, May 16, 2013